Skip to content
CompletedN/A

Neuromodulation to Facilitate the Effect of Ketamine

NCT01816958 · TMS/ketamine · The Neuroscience Center, LLC

Closed to entry
Status
Not accepting participants
Not applicable
Phase
35
Target enrolment
1
Study sites
1 US states

What it is testing

Summary

application of external neuromodulation along with ketamine infusion.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Global Assessment of Function in DSM-4R

    Measured over up to 3 years

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years
Ages
All
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: * chronically ill, * treatment-resistant Exclusion Criteria: * active psychosis

Where

1 study site

FacilityCityRegionCountry
The Neuroscience CenterDeerfieldIllinoisUnited States

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT01816958 on ClinicalTrials.gov →

Last updated in the registry 2013-03-22. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits

Substance

Recruiting in